Search
Clinical trials are the engine of progress in oncology, offering the most promising potential therapies and, often, the treatment of choice for cancer patients. However, navigating the landscape of trial enrollment—especially for genitourinary malignancies—requires a specialized, collaborative, and patient-centered approach that is rarely incorporated in standard continuing medical education.
We invite you to join us for an innovative one-day educational meeting that bridges this critical gap. This forum convenes leading academic and community clinicians and researchers to enhance collaboration, share cutting-edge science, and strategize on best practices for clinical trial participation in kidney, bladder, and prostate cancer.
Registration will open in spring 2026.
What is ANCO’s Industry Registration policy?
At ANCO, we strive to foster meaningful connections and facilitate valuable interactions among participants at our meetings. To ensure a fair distribution of attendance and provide an opportunity for various stakeholders to participate and engage with the cancer care community at large, industry registrations for our meetings are intentionally limited.Industry Registrations are limited to a maximum of three representatives per company, from companies who are not exhibiting at the meeting, with a maximum of 15 companies.
This policy is contingent upon meeting registrations and venue capacity. If we do have additional space, we will accept more representatives.
How does the ANCO Industry Registration waitlist approval process work?
Apply to Become a Member
4225 Solano Ave, #764 Napa, CA 94558 Phone (415) 472-3960
Association of Northern California Oncologists © 2025 | Privacy Policy | Disclaimer